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Abstract. Peroxisome-to-mitochondrion  mistargeting 
of the homodimeric enzyme alanine:glyoxylate  ami- 
notransferase 1 (AGT) in the autosomal recessive dis- 
ease primary hyperoxaluria type 1 (PH1) is associated 
with the combined presence of a normally occurring 
PronLeu polymorphism and a PHi-specific GlylToArg 
mutation. The former leads to the formation of a novel 
NH2-terminal mitochondrial targeting sequence 
(MTS), which although sufficient to direct the import of 
in vitro-translated AGT into isolated mitochondria, re- 
quires the additional presence of the Gly170Arg muta- 
tion to function efficiently in whole cells. The role of 
this mutation in the mistargeting phenomenon has re- 
mained elusive. It does not interfere with the peroxiso- 
mal targeting or import of AGT. In the present study, 
we have investigated the role of the Gly~70Arg  mutation 
in AGT mistargeting. In addition, our studies have led 
us to examine the relationship between the oligomeric 
status of AGT and the peroxisomal and mitochondrial 
import processes. The results obtained show that in 
vitro-translated AGT rapidly forms dimers that do not 
readily exchange subunits. Although the presence of 
the PronLeu or Gly170Arg substitutions alone had no 
effect on dimerization, their combined presence abol- 
ished homodimerization in vitro. However, AGT con- 
taining both substitutions was still able to form het- 
erodimers in vitro with either normal AGT or AGT 
containing either substitution alone. Expression of vari- 
ous combinations of normal and mutant, as well as 
epitope-tagged and untagged forms of AGT in whole 
cells showed that normal AGT rapidly dimerizes in the 
cytosol and is imported into peroxisomes as a dimer. 
This dimerization prevents mitochondrial import, even 
when the AGT possesses an MTS generated by the 
Pro11Leu substitution. The additional presence of the 
Gly170Arg substitution impairs dimerization sufficiently 
to allow mitochondrial import. Pharmacological inhibi- 
tion of mitochondrial import allows AGT containing 
both substitutions to be imported into peroxisomes effi- 
ciently, showing that AGT dimerization is not a prereq- 
uisite for peroxisomal import. 
B 
OTH mitochondrial and peroxisomal precursor pro- 
teins are synthesized on free polyribosomes in the 
cytosol and are imported posttranslationally into 
their respective  organelles (17, 25). Despite these similari- 
ties, many studies suggest  that the targeting information 
and structural requirements for mitochondrial and peroxi- 
somal protein import are very different. Most mitochon- 
drial precursor proteins are synthesized with NH2-termi- 
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nal  extensions,  which  are  cleaved  after  mitochondrial 
import (1, 13). Targeting information in the presequence is 
determined by secondary rather than primary structure. In 
particular, the ability  to form positively  charged amphi- 
pathic ~ helices appears to be crucial (28, 36). It is widely 
accepted that mitochondrial precursor proteins must be 
maintained in a partially unfolded monomeric state to be 
translocated across  the mitochondrial membrane (8, 29). 
Indeed, mitochondrial proteins that do assume  a folded 
configuration in the cytosol appear to be unfolded during 
import  (3,  8).  Conversely,  tightly folded  and  disulfide 
bonded proteins  or  large  oligomeric  complexes  are  not 
competent for import into mitochondria (3, 8). 
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have been identified within mammalian peroxisomal ma- 
trix proteins  (30).  The first  to  be  characterized  (PTS1) 
consists of a COOH-terminal tripeptide with a consensus 
S(A,C)-K(R,H)-L(M)  (12,  32).  This  motif  is  found  in 
many peroxisomal matrix proteins and is not cleaved after 
import. The second mammalian PTS (PTS2), which so far 
has only been identified in 3-ketoacyl-CoA thiolase, con- 
sists  of a  cleavable  NH2-terminal  sequence  of 26  or 36 
amino acids (depending on species) with a consensus mot'if 
of Xn-RL-Xs-HL-Xn (24, 31). It should be noted, however, 
that many peroxisomal matrix proteins do not appear to 
contain either a PTS1 or PTS2 sequence, as defined above. 
In contrast to mitochondrial precursors, many peroxiso- 
mal proteins are capable of productive folding and oligo- 
merization in the cytosol. For example, the peroxisomal 
protein firefly luciferase (FFL) is efficiently folded when 
synthesized in reticulocyte lysates in vitro (14).  Also, in 
cells from patients with a  defect in the import of PTS1- 
containing proteins, the peroxisomal enzyme catalase ap- 
pears to assemble into catalytically active tetramers in the 
cytosol (20). More recent studies have provided evidence 
that  cytosotically  assembled  protein  oligomers  can  be 
translocated across the peroxisomal membrane of yeast. 
Thus, homodimers of yeast thiolase and homotrimers of 
bacterial chloramphenicol acetyltransferase (CAT) fused 
to  a  PTS1  can  be  translocated  across  the  peroxisomal 
membrane of Saccharomyces cerevisiae without previous 
disassembly (10, 18). Further evidence supporting a mech- 
anism of translocation that can accommodate large oligo- 
meric protein complexes has been provided by the work of 
Walton et al., who have demonstrated that 4-9-nm colloi- 
dal  gold  particles  coated with  a  human  serum  albumin 
(HSA)-PTS1 peptide conjugate can be imported into per- 
oxisomes  after microinjection into human  fibroblasts  in 
culture (37). 
In humans, the liver-specific enzyme alanine:glyoxylate 
aminotransferase 1 (AGT) is localized to the peroxisomal 
matrix, where it exists as a homodimer (5, 22). The PTS of 
AGT has yet to be completely defined. Although recent 
studies have indicated that AGT is imported via the PTS1- 
dependent pathway, the COOH terminus of human AGT 
(KKL) does not fit the previously defined PTS1 consensus. 
Despite  the  COOH-terminal  tripeptide  of  AGT  being 
necessary for targeting, it has been shown to be insuffi- 
cient  to direct the  peroxisomal import of the  bona fide 
peroxisomal matrix protein FFL and the bacterial reporter 
protein CAT (21). These observations have led to the sug- 
gestion that the PTS1 of AGT is more complex than a sim- 
ple COOH-terminal tripeptide. In a subset of patients with 
the  rare  autosomal  recessive disorder primary hyperox- 
aluria type 1 (PH1), disease results from the mislocaliza- 
tion of AGT to mitochondria rather than to peroxisomes 
(6). Previously, we have demonstrated that mistargeting of 
AGT in these individuals is associated with the combined 
1. Abbreviations used in this paper. AGT, alanine:glyoxylate aminotrans- 
ferase  1;  BS3,  bis (sulfosuccinimidyl) suberate; CAT,  chloramphenicol 
acetyltransferase;  CCCP,  carbonyl  cyanide  m-chlorophenylhydrazone; 
FFL, firefly luciferase; HSA, human serum albumin; MTS, mitochondrial 
targeting sequence; PBSA, phosphate-buffered saline A; PH1, primary 
hyperoxaluria type 1; PTS, peroxisomal targeting sequence. 
presence of two normally occurring polymorphisms, PrthiLeu 
and  Ile340Met,  and  a  PHI-specific  Gly170Arg  mutation 
(27). The PrOllLeU substitution was predicted to greatly 
enhance  the  likelihood  of  the  NH2-terminal  region  of 
AGT folding as a  positively charged amphiphilic a-helix 
that might then function as an MTS. Indeed, in isolated 
mitochondrial  import  assays,  the  Pro11Leu  substitution 
alone was shown to be sufficient for the import of at least a 
small proportion of in vitro-translated AGT, while Glyt70Arg 
and Ile340Met were neither necessary nor sufficient for mi- 
tochondrial  import  (26).  In  whole  cells,  however,  both 
Pro11Leu and Gly170Arg are necessary for significant mito- 
chondrial import, although neither is sufficient alone (21, 
27). Ile340Met was neither necessary nor sufficient. Since 
neither Pro11Leu nor GlytToArg amino acid substitutions 
interfere with  peroxisomal import  (21),  the  role  of the 
Gly170Arg mutation in  the peroxisome-to-mitochondrion 
mistargeting of AGT has remained enigmatic. 
In this paper, we have attempted to resolve this issue. 
The results presented show that normal AGT is imported 
into peroxisomes as a dimer, although dimerization is not 
a prerequisite for peroxisomal import. On the other hand, 
mutant AGT can only be imported into mitochondria as a 
monomer.  The  peroxisome-to-mitochondrion mistarget- 
ing of AGT in PH1 is, therefore, caused by the combined 
effects of (a)  the  generation  of an  MTS  caused  by the 
PrOllLeU polymorphism; and (b) the inhibition of dimer- 
ization caused by the combined presence of the Pro11Leu 
polymorphism  and  the  Gly170Arg  mutation.  This  is  not 
only the first demonstration of the peroxisomal import of 
a naturally occurring oligomeric PTS1 protein, but also the 
first demonstration that oligomerization can determine, at 
least in part, the intracellular fate of a protein. 
Materials and Methods 
Construction of  Expression Plasmids 
The various AGT expression plasmids used in this study are described in 
Table I. The construction of plasmids encoding normal human AGT, the 
various mutant forms of human AGT (AGT  A, AGT  s, AGT  AB, AGT  ABe, 
and AGTA1), and FFL in the in vitro expression vector pBluescriptKS  ÷ 
and the mammalian expression vector pHYK have been described previ- 
ously (21, 26). To produce COOH-terminal, myc epitope-tagged deriva- 
tives of these AGT constructs, normal human AGT was PCR amplified 
with the top-strand primer CTTCTCCTTCTACCTGGACA  and the bot- 
tom-strand  primer  CGGATCGGATCCTCACAGGTCCTCCTCGGA- 
GATCAGC1TCTGCTCGCCGCCCTTGGGGCAGTGCTG.  The 3' end 
of the bottom-strand primer (italicized) is complementary to basepairs 
1289-1275  of human AGT cDNA and then encodes two glycine residues 
followed by the 10-amino acid c-myc epitope (bold), a stop codon, and a 
BamHI restriction site (underlined). The top-strand primer is complemen- 
tary to basepairs 833-852  of human AGT cDNA and is upstream of a 
unique ApaI restriction site (basepair 1180) in the eDNA. The PCR prod- 
uct was digested with ApaI and BamHI, and was cloned into the appropri- 
ate ApaI- and BamHI-digested plasmids to generate each of the myc- 
tagged plasmids described in Table I. Thus, in each myc-tagged AGT con- 
struct, the COOH-terminal Frs1 tripeptide has been replaced with two 
glycine residues followed by the myc epitope (EQKLISEEDL). All se- 
quences generated by PCR were sequenced. 
In Vitro Transcription and Translation 
For in vitro transcription, N1  I~g of plasmid DNA was linearized with 
BamHI before transcription with T3 RNA polymerase (Promega, South- 
ampton, UK) according to the manufacturer's instructions. Aliquots of in 
vitro transcription reactions (1 ~1 and N1 ~g of RNA) were used directly 
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Plasmid  Previous name*  Description 
AGT 
AGT  A 
AGT  8 
AGT  AB 
AGT  ABc 
AGTA1 
AGT-myc 
AGTA-myc 
AGTa-myc 
AGTAB-myc 
AGTABC-myc 
AGT~/AGTPg  i 
AGTtg  i 
AGT  p'i 
AGT  ~i 
AGT  Irm 
AGT  ¢'A  1 
Normal AGT encoded by the major allele 
AGT containing a Pro  11Leu substitution 
AGT containing a GlylToArg substitution 
AGT containing both ProllLeu and Glyl70Arg substitutions 
AGT containing Pro  llLeu, Glyl70Arg, and Ile340Met substitutions 
COOH-terminal KKL of normal AGT deleted 
COOH-terminal KKL of AGT replaced with c-myc epitope 
COOH-terminal KKL of AGT  n replaced with c-myc epitope 
COOH-terminal KKL of AGT  B replaced with c-myc epitope 
COOH-terminal KKL of AGT  AB replaced with c-myc epitope 
COOH-terminal KKL of AGT  Aac replaced with c-myc epitope 
For expression in vitro, each of the cDNA constructs was cloned into pBluescriptlIKS  +. For expression  by transfection in whole cells, the constructs were cloned into the mamma- 
lian expression vector pHYK. 
*The previous names are those used in reference 21. 
for in vitro translation in reticulocyte lysates (Promega) containing [35S]L- 
methionine (NEN Dupont, Stevenage, UK) following the manufacturer's 
instructions for 40 rain at 30°C. 
Preparation of  Liver Homogenates 
Approximately 0.5  g  of frozen human  liver was finely sliced and  sus- 
pended in 5 ml of ice-cold phosphate-buffered saline A  (PBSA) and ho- 
mogenized by five passes through a tight-fitting glass/Teflon motor-driven 
homogenizer. The homogenate was centrifuged at 25,000 g for 30 min at 
4°C. The supernatant was retained and diluted with ice-cold PBSA to a 
concentration of 5 v.g protein/ml. 
A-Sepharose was collected by centrifugation, and the pellets washed five 
times in 300 p.l of immunoprecipitation buffer. Proteins were eluted from 
washed pellets by boiling in 30 ixl of sample loading buffer (125 mM Tris/ 
HC1, 2% SDS [wt/vol], 5% [3-mercaptoethanol [vol/vol], 20% glycerol [wt/ 
vol],  0.0025%  bromophenol blue  [wt/vol],  pH  6.8),  resolved by  SDS- 
PAGE, and visualized by fluorography. 
Cell Culture and Transfection 
SV-40-transformed monkey kidney cells (COS-l) were grown in DME 
Chemical Cross-linking 
The water-soluble homobifunctional cross-linker bis (sulfosuccinimidyl) 
suberate (BS3; Pierce, UK) was used to cross-link AGT in various frac- 
tions as follows: 
In Vitro-translatedAGT. Aliquots of translation reactions (5 Ixl) were 
diluted fivefold in cross-linking buffer (100 mM potassium phosphate, pH 
7A) containing 1 mM BS3, and were incubated for 30 min at room temper- 
ature. Cross-linking was terminated by the addition of 1 ixl of 1 M Tris/ 
HCI, pH 7.4. Aliquots (5 ~l) of cross-linking reactions were analyzed by 
SDS-PAGE followed by fluorography. Where indicated, translation reac- 
tions were treated with 150 mU of potato apyrase (Sigma, Poole, UK) for 
30 min at 30°C before cross-linking to deplete ATP from the reticulocyte 
lysate. 
AGT in Human Liver Homogenates. Aliquots (5 Ixl and ~25  Ixg of pro- 
tein) of liver homogenates were diluted fivefold in cross-linking buffer 
containing BS3 at the concentrations indicated. Reactions proceeded for 
30 min at room temperature and were terminated by the addition of 1 p~l 
of 1 M  Tris/HCl, pH 7.4.  Aliquots of reactions were resolved by SDS- 
PAGE, transferred to nitrocellulose membranes, and analyzed by immu- 
noblotting with rabbit anti-human AGT polyclonal antisera, followed by 
an HRP-conjugated goat anti-rabbit IgG (Sigma) and visualization by en- 
hanced chemiluminescence (ECL; Amersham International, Amersham, 
OK). 
Purified Human AGT. Approximately 2  I~g of purified normal human 
AGT was diluted into 25 ~1 of cross-linking buffer and cross-linked with 
BS3  at the concentrations indicated. After termination of cross-linking, 
reactions were resolved by SDS-PAGE, and AGT was visualized by silver 
staining. 
lmmunoprecipitation 
For immunoprecipitation of in vitro--translated proteins, 15-p~1 aliquots of 
reactions were diluted into 300 p~l of immur Jprecipitation buffer (150 mM 
NaCI,  1 mM EDTA, 0.1% Triton X-100, 50 mM TrislHC1,  pH 8.0)  and 
predeared by incubation with 5  I~g of preswoUen protein A-Sepharose 
(Sigma) for 1 h at 4°C. Samples were then centrifuged for 1 min at 13,000 
rpm in a microfuge to pellet the protein A-Sepharose. The supernatants 
were removed and incubated for 2 h at 4°C with 20 Ixl of tissue culture me- 
dium containing the mouse anti-myc mAb 9El0 (~2 mg proteirdml). An- 
tibody/antigen complexes were then precipitated by adding 5 l~g of pre- 
swollen protein A-Sepharose and incubating for 1 h  at 4°C.  Protein 
Figure 1.  Chemical cross-linking of in vitro-translated AGT. Ali- 
quots  of in  vitro  translation  reactions,  programmed  with  tran- 
scripts encoding the proteins indicated, were either cross-linked 
with the chemical cross-linker BS3  (+BS3)  or uncross-linked 
(-BS3).  For descriptions of AGT,  AGTA1,  AGT A, AGT B, and 
AGT AB, see Table I. Firefly luciferase (LUC) was used as a con- 
trol.  Where  indicated,  endogenous ATP  was  depleted from  ly- 
sates before cross-linking by incubation with apyrase (+/-  Apy). 
After cross-linking, samples were resolved by SDS-PAGE on 8% 
gels, and  the  [35S]L-methionine-labeled in vitro-translated  pro- 
teins were visualized by fluorography. The migration position of 
monomeric AGT (open arrow) and the ~90-kD AGT cross-link- 
ing product (filled arrow) are indicated. Positions of the molecu- 
lar  mass markers  (in  kilodaltons)  are  shown on the right-hand 
side. Although the intensities of the 90-kD cross-linked products 
vary between the different AGT  constructs, with the exception 
only of AGT AB, they are proportional to the intensities of the re- 
spective  uncross-linked  monomers.  Therefore,  this  variation 
probably  results  from  different  translation  efficiencies  rather 
than from any differences in the efficiencies of cross-linking. No 
90-kD  product  was  apparent  when  AGT AB  was  cross-linked, 
even on longer exposures of the autoradiograms. 
Leiper et al. Dimerization and AGT lntracellular Targeting  941 Figure 2.  Immunoprecipitation of epitope-tagged AGT. (A) Aliquots of in vitro translation reactions, programmed with the transcripts 
indicated, were either directly resolved by SDS-PAGE  on 10% gels (lanes 1-4) or immunoprecipitated with an anti-myc mAb (lanes 
5-8), and the products were then resolved by SDS-PAGE on 10% gels. In lanes 3  and 8, AGT and AGT-myc were cotranslated (CT), 
whereas in lanes 4 and 8, the proteins were translated separately and the products mixed posttranslationally (PT). The migration posi- 
tions of epitope-tagged (AGT-myc) and untagged AGT  are indicated. (B) In vitro translation reactions were programmed with tran- 
scripts encoding the various AGTs indicated. After translation, aliquots of reactions were either directly resolved by SDS-PAGE  on 
10% gels (lanes 1-7) or immunoprecipitated with an anti-myc mAb and resolved by SDS-PAGE on t0% gels (lanes 8-14). The migra- 
tion positions of epitope-tagged (AGT-myc) and untagged AGT are indicated. Diagonal lines indicate that a particular construct is not 
present; dashes indicate that the construct is normal, i.e., it contains neither the A  nor B  substitutions. 
supplemented with 10% FCS at 37°C under 5% CO2. Cells were split 1:10 
on reaching confluence. For electroporation, cells were trypsinized, col- 
lected by centrifugation, washed in ice-cold PBSA, and resuspended in 
PBSA at a  concentration of 106-107 cells/ml. Aliquots of cells (150  I~1) 
were transferred to a 0.4-cm electroporation cuvette (Bio-Rad Laborato- 
ries, Richmond, CA), mixed with 50 ~1 of plasmid DNA (200 I~g/ml), and 
incubated on ice for 10 min. In cotransfection experiments, the myc-tagged 
AGT  DNA  to  untagged  AGT  DNA  ratio  was  1:25,  unless otherwise 
stated. After delivery of a pulse (0.25  kV at 125 I~F) in a Bio-Rad gene 
pulser, the cells were incubated on ice for 10 min. Subsequently, 104-105 
cells were plated in growth medium onto 13-mm glass microscope cover- 
slips. 48 h after transfection, the cells were processed for indirect immu- 
nofluorescence microscopy. In some experiments, cells were grown in me- 
dium supplemented with 20 ~M carbonyl cyanide m-chlorophenylhydrazone 
(CCCP) for 48 h before processing. In many cases, parallel experiments 
were carried out in which plasmids were transfected into human fibro- 
blasts by intranuclear microinjection essentially as described previously (21). 
Immunofluorescence Microscopy 
Except when transfected cells were to be double-labeled for AGT and the 
peroxisomal  marker  catalase,  cells  were  incubated  with  200  nM  Mi- 
toTracker (Molecular Probes, Cambridge Bioscience, Cambridge, UK) for 
15 min at 37°C to label mitochondria. The cells were then washed in PBS 
and fixed in freshly prepared 3% (wt/vol) paraformaldehyde for 15 min at 
room temperature. The plasma and peroxisomal membranes were then 
permeabilized with 1% Triton X-100 for 15 min at room temperature. In 
some experiments, cells were differentially permeabilized with 25 Ixg/ml 
digitonin, instead of Triton X-100, for 5 min at room temperature to selec- 
tively permeabilize the plasma membrane. The cells were then processed 
for single- or double-label indirect immunofluorescence using the follow- 
ing antibodies: rabbit polyclonal anti-human AGT,  mouse monoclonal 
anti-myc (9El0), and rabbit and guinea pig polyclonal anti-human catalase. 
AGT was visualized with FITC-conjugated goat anti-rabbit IgG (Sigma), 
and myc was visualized with biotinylated horse anti-mouse IgG and Texas 
red avidin D  or fluorescein streptavidin (Vector Laboratories, Peterbor- 
ough, UK). Catalase was visualized with either biotinylated goat anti- 
guinea pig IgG and Texas red avidin D or FITC-conjugated goat anti-rab- 
bit IgG. All incubations were performed at room temperature for 15 min 
in PBS containing 3% BSA. After each incubation, the cells were washed 
in PBS. The coverslips were mounted on glass slides in Mowiol (Harlow 
Chemical  Co.  Ltd.,  Harlow,  UK)  containing diazabicyclo[2,2,2]octane 
(DABCO, Sigma). The fluorescent staining pattern was viewed in a con- 
focal laser-scanning microscope (MRC 1000; Bio Rad). The captured im- 
ages were processed using Adobe Photoshop software (Adobe Systems 
Inc., Mountain View, CA), and were recorded on TMAX 100 ASA B/W 
film (Eastman Kodak Co., Rochester, NY). 
The Joumal of Cell Biology, Volume 135, 1996  942 Figure 3.  Intracellular localization of AGT and AGT-myc in COS-1 cells. (A-D) COS-1 cells transfected with normal AGT (A and B) 
or AGT-myc (C and D) were double labeled for either AGT (A) and catalase (B) or myc (C) and catalase (D). (E-H) COS-1 cells 
cotransfected with either AGT-myc and AGT (E and F) or AGT-myc and AGTA1 (G and H) were double labeled for myc (E and G) 
and catalase (F and H). Bar, 10 p~m. 
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The Combined Presence of  ero11Leu and Gly17oArg 
Amino Acid Substitutions Inhibit AGT Dimerization 
In Vitro 
AGT  purified  from a  variety of mammalian livers  has 
been shown to exist as a homodimer (34). To test whether 
AGT translated in vitro is able to dimerize, we examined 
the oligomeric state of in vitro-translated AGT by chemi- 
cal cross-linking (Fig.  1).  SDS-PAGE  of in vitro-trans- 
lated normal human AGT produced a band of ~43 kD, a 
size consistent with the predicted molecular mass of mo- 
nomeric AGT (33). After cross-linking, an additional band 
of ~90  kD was produced, close to the expected size of 
dimerized AGT. Since the folding and oligomerization of 
cytosolic proteins is mediated by molecular chaperones in 
an ATP-dependent fashion (9), we investigated the effect 
of ATP depletion (using apyrase) on the posttranslational 
cross-linking (dimerization) reaction. Posttranslational ATP 
depletion had no effect on the production of the 90-kD 
cross-linked product, suggesting that dimerization occurs 
rapidly in vitro (i.e., before the addition of apyrase). In ad- 
dition,  cross-linking  was  unaffected by  removal  of  the 
COOH-terminal PTS1 tripeptide from AGT. 
To confirm that the ~90-kD cross-linking product did 
indeed represent dimerized AGT, we constructed a series 
of AGT constructs in which the  COOH-terminal  PTS1 
tripeptide was replaced with 12 amino acids containing an 
epitope tag from c-myc. After translation in vitro, myc- 
tagged  normal AGT produced  a  protein  that migrated 
more slowly than the untagged protein, consistent with the 
net addition of nine amino acids (Fig. 2 A). Normal AGT 
and AGT-myc were either translated separately, cotrans- 
lated, or translated separately and mixed posttranslation- 
ally. Translation reactions were subjected to immunopre- 
cipitation with an anti-myc antibody, and aliquots of the 
initial  translation  reaction  and  the  immunoprecipitates 
were resolved by SDS-PAGE (Fig. 2 A). When translated 
alone,  untagged  normal  AGT  was  not  immunoprecipi- 
tared  by the  anti-myc antibody, whereas  the  AGT-myc 
was  efficiently precipitated (Fig. 2 A).  When AGT and 
AGT-myc were cotranslated, untagged AGT was immu- 
noprecipitated. In cotranslations where AGT was in ex- 
cess over AGT-myc (by ~10-fold), AGT and AGT-myc 
were coprecipitated in approximately equimolar amounts, 
confirming that AGT/AGT-myc heterodimers had formed, 
and that most, if not all, of in vitro-translated AGT does 
indeed dimerize (Fig. 2 B). When the two proteins were 
translated separately and then mixed posttranslationally, 
untagged AGT was not coprecipitated with AGT-myc, in- 
dicating that once formed, AGT dimers do not readily ex- 
change subunits (Fig. 2 A). 
To determine the effect of AGT substitutions associated 
with  peroxisome-to-mitochondrion mistargeting  in  PH1 
on AGT dimerization, we performed chemical cross-link- 
ing of in vitro-translated AGT encoding various combina- 
tions of these substitutions (Fig.  1).  Cross-linking of in 
vitro-translated AGT  A and AGT  B also produced an ,--~90- 
kD product, indicating that neither of these substitutions 
alone interferes with AGT dimerization in vitro. In con- 
trast, the combined presence of both substitutions in AGT  AB 
completely abolished the production of the ~90-kD band, 
suggesting that in vitro, these substitutions inhibit AGT 
dimerization. Similarly, cross-linking of AGT  ABe failed to 
produce a 90-kD product, indicating that the presence of 
the C substitution does not affect the ability of the A  and 
B substitutions to inhibit AGT dimerization in vitro (data 
not  shown).  When  epitope-tagged  and  untagged  AGT 
constructs encoding either the A, the B, or both the A and 
B  substitutions  were  cotranslated  and  immunoprecipi- 
tated, we observed that either substitution alone did not 
affect the ability of tagged AGT to coprecipitate untagged 
AGT (Fig. 2 B). Consistent with our chemical cross-link- 
ing data,  however,  the  two substitutions together  abol- 
ished  coprecipitation;  i.e.,  AGTAB/AGTAB-myc  did  not 
dimerize. However, AGTAS-myc was able to coprecipitate 
normal AGT (Fig. 2 B), AGT  A and AGT  s (data not shown), 
indicating that the combined presence of A and B substi- 
tutions in both potential subunits is required to inhibit the 
formation of AGT dimers in vitro. 
Normal AGT Is Imported Into Peroxisomes as a Dimer 
Our studies of AGT dimerization in vitro raise the possi- 
bility that the inhibition of AGT dimerization caused by 
the combined presence of the A and B substitutions might 
play a role in the peroxisome-to-mitochondrion mistarget- 
ing associated with these substitutions in PH1. To test this 
hypothesis, we  expressed  various combinations of myc- 
tagged and untagged AGT constructs containing either A 
or B substitutions or both by transfection in COS-1 cells, 
and determined the intracellular localization of the result- 
ing proteins  by immunofluorescence microscopy. When 
normal AGT was expressed by transfection in COS-1 cells 
(which do not normally express AGT), it was imported 
into a particulate compartment that labeled for the peroxi- 
somal marker enzyme catalase (i.e., peroxisomes; Fig. 3, A 
and B). In contrast, AGT-myc was dispersed throughout 
the cytosol, with no apparent evidence of localization to a 
particulate compartment (Fig. 3, C and D). These data are 
consistent with our previous observations that the COOH- 
terminal tripeptide of AGT is absolutely required for per- 
oxisomal import (21). When AGT-myc was cotransfected 
with normal AGT (at a ratio of 1"25), however, the myc- 
tagged protein colocahzed with the peroxisomal marker 
catalase (Fig. 3, E and F). That AGT-myc had indeed been 
imported into peroxisomes rather than simply binding to 
the cytosolic face of the peroxisomal membrane was con- 
firmed by differential digitonin permeabilization  of the 
plasma membrane before immunolabeling (data not shown). 
Presumably because of heterogeneity in the relative up- 
take and expression of the AGT and AGT-myc expression 
plasmids in electroporated COS-1 cells, the distribution of 
AGT-myc varied widely between individual cotransfected 
cells. For example, although most cells showed both per- 
oxisomal and cytosolic labeling, in ~10%, it was entirely 
peroxisomal, and in a few, it was wholly cytosolic. Interest- 
ingly, in parallel experiments in which the AGT and AGT- 
myc expression plasmids were  directly injected into the 
nuclei of human fibrobtasts, the distribution of AGT-myc 
was exclusively peroxisomal in all cells (data not shown). 
Cotransfection of AGT-myc with AGTA1 in COS-1 cells 
resulted in a cytosolic (diffuse) distribution of AGT-myc, 
The Journal of Cell Biology, Volume 135, 1996  944 Figure 4.  Intracellular localization of mutant AGT in COS-1 cells. (A-D) COS-1 cells transfected with AGT  AB were double labeled for 
either AGT (A) and MitoTracker (B) or AGT (C) and catalase (D). (E-H) Similarly, cells transfected with AGTAB-myc were double la- 
beled for either myc (E) and MitoTracker (F) or myc (G) and catalase (H). Bar, 10 txm. 
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dent on an intact PTS in its dimerizing partner (Fig 3, G 
and H). Taken together, these data indicate that AGT can 
be targeted to peroxisomes and committed to peroxisomal 
import via a PTSl-dependent pathway as a dimer. 
Mitochondrial Import of  Mutant AGT Is Blocked 
by Dimerization 
Because AGT and AGT  Aa were able to form heterodimers 
in vitro, we investigated the ability of AGT to influence 
the intracellular localization of AGT  AB.  Consistent with 
our previous observations (21, 27), when AGT  AB was ex- 
pressed by transfection in COS-1 cells, the protein local- 
ized predominantly to the mitochondria, as indicated by its 
colocalization with the mitochondrial marker MitoTracker 
(Molecular Probes), although a small but significant pro- 
portion  localized  to  peroxisomes  (Fig.  4, A-D).  When 
AGTAB-myc was expressed in COS-1 cells, the protein was 
exclusively localized to the mitochondria (Fig 4, E and F). 
No localization in the peroxisomes was apparent, presum- 
ably because the AGT PTS1 tripeptide has been replaced 
with  the myc epitope in this protein (Fig. 4,  G  and H). 
When AGTAB-myc was coexpressed with normal AGT at 
a ratio of 1:25, the myc-tagged protein localized to peroxi- 
somes but not to the mitochondria (Fig. 5, A-D). Coex- 
pression of AGTAB-myc with AGTA1 resulted in a  pre- 
dominantly cytosolic localization of AGTABmyc (Fig. 5, E 
and F). These data suggest that AGTAB-myc/AGT dimers 
form rapidly in the cytosol, and that dimerization makes 
AGTAB-myc unavailable  for mitochondrial import.  Fur- 
thermore,  once AGTAB-myc/AGT dimers  have  formed, 
AGTAB-myc does not subsequently become available for 
mitochondrial import, even in the absence of peroxisomal 
import. 
In contrast to the above, when we coexpressed AGT  AB- 
myc with AGT  AB, the myc- tagged protein was exclusively 
localized to the mitochondria (Fig. 6, A-D) even though 
we showed previously that significant amounts of AGT  AB 
would also be localized in the peroxisomes (Fig. 4, A-D). 
Similar results were obtained when AGT  ABc and AGT  ABc- 
myc were coexpressed (data not shown). This is consistent 
with our in vitro translation data, which indicated that the 
combined presence of substitutions A and B inhibits AGT 
homodimerization and that the inhibition of dimerization 
is not affected by the presence of the C substitution. When 
we coexpressed AGTAB-myc and AGT  Aa in COS-1 cells 
that had been treated with CCCP to inhibit mitochondrial 
import, however, we observed that a small but significant 
proportion of myc-tagged protein was imported into per- 
oxisomes, although the majority of the protein remained 
in  the  cytosol (Fig.  6,  E  and F).  Because  AGTAB-myc 
could only be imported into peroxisomes by dimerizing 
with AGT  Aa, this observation suggests that in whole cells, 
the effect of the A  and B  substitutions is to slow rather 
than to abolish AGT dimerization. Interestingly, when the 
mitochondrial import of AGT  AB is inhibited by CCCP, the 
protein is targeted to peroxisomes (Fig. 6 G) as efficiently 
as normal AGT expressed in the presence (Fig. 6 H) or ab- 
sence (Fig. 3 A) of CCCP. The small proportion of AGT  AB- 
myc imported into  peroxisomes when coexpressed with 
AGT  AB in CCCP-treated cells indicates that only a small 
proportion dimerizes (with AGTAB). Therefore, provided 
CCCP does not specifically retard the rate of formation 
of AGTAB/AGTAa-myc heterodimers (as compared with 
AGTAB/AGT  AB homodimers) or reveal a cryptic PTS within 
AGTAB-myc, it is probable that the majority of AGT  A8 is 
imported  into  peroxisomes as  a  monomer. Thus,  while 
normal AGT appears to be imported into peroxisomes as 
a dimer, dimerization does not appear to be a prerequisite 
for peroxisomal import. 
Both Normal and Mutant AGT Is Dimerized in the 
Human Liver 
To determine the oligomeric status of AGT in human liv- 
ers, we performed chemical cross-linking of human liver 
homogenates from a normal individual, in whom AGT is 
exclusively peroxisomal; a PHI patient homozygous for A, 
B, and C  substitutions, in whom >90%  of AGT is mito- 
chondrial (patient 2 in reference 6, patient G in reference 
27); and a  panperoxisomal disease patient who was het- 
erozygous for AGT  A and AGT, in whom AGT is mainly 
cytosolic (patient 2 in reference 7, complementation group 
new and previously unrecognized; Naidu, S.; A.B. Moser, 
C.J. Danpure, L. Civitello, and H.W. Moser, Proceedings 
of the First Conjoint Meeting of the Child Neurology Soci- 
ety and  the  International  Child  Neurology Association, 
San Francisco, October 2-8,  1994). SDS-PAGE and im- 
munoblotting of liver homogenates from each individual 
revealed a single immunoreactive band of ~43 kD before 
cross-linking, which corresponds to the predicted molecu- 
lar mass of monomeric AGT (Fig. 7, A-C). At low cross- 
linker concentrations in all samples, an additional band of 
~90 kD, the expected size of dimerized AGT, was the pre- 
dominant cross-linked product. However, at higher cross- 
linker concentrations, the intensity of the ~90-kD  band 
decreased concomitantly with an increase in a band of ~68 
kD. While it is possible that the ~68-kD band may be the 
product of AGT cross-linked to a protein of ,~25 kD, its 
appearance at higher cross-linker concentrations and the 
associated decrease in the ~90-kD band suggested to us 
that it more likely represents a more highly cross-linked, 
and therefore more compact form of dimerized AGT. To 
investigate this possibility, we performed cross-linking of 
purified normal human AGT (Fig. 7 D). In this prepara- 
tion, AGT is the only protein visible by silver staining, and 
in the absence of cross-linker, migrates with an apparent 
molecular mass of ~43  kD. When cross-linked with low 
concentrations of cross-linker, the ~43-kD band becomes 
more diffuse, probably because of intrachain cross-linking, 
and a band of ,~90 kD is produced. At higher cross-linker 
concentrations, a second cross-linked product of ~68 kD 
becomes  apparent,  confirming  that  both  cross-linking 
products do indeed represent AGT dimers. 
These data indicate that despite the presence of substi- 
tutions that markedly retard AGT dimerization in vitro in 
both cellular and noncellular systems, AGT  AB can dimer- 
ize in human liver mitochondria. It remains to be clarified 
whether this is caused by the ability of AGT  AB to dimerize 
more efficiently in the mitochondria than in the cytosol, or 
whether it simply reflects the vastly different time scales 
involved (0.5-48 h for the in vitro experiments, but proba- 
bly days to weeks for the PH1 patient). However, prelimi- 
The Journal of Cell Biology, Volume 135, 1996  946 Figure 5.  Intracellular localization of mutant AGT in COS-1 cells when coexpressed with normal AGT. COS-I cells were cotransfected 
with either AGTAB-myc and normal AGT (A-D) or AGTAB-myc and AGTA1 (E-H). Cells were double labeled for either myc (A and 
E) and MitoTracker (B and F) or myc (C and G) and catalase (D and H). Bar, 10 i~m. 
Leiper et al. Dimerization and AGT lntracellular Targeting  947 Figure 6.  Intracellular localization of mutant  AGT in COS-1 cells treated with CCCP. (A-D) COS-1 cells were cotransfected with 
AGTAB-myc  and AGT  AB and were double labeled for either myc (A) and MitoTracker (B) or myc (C) and catalase (D). (E and F) Cells 
were cotransfected with AGTAa-myc and AGT  AB, cultured in the presence of CCCP, and double labeled for myc (E) and catalase (F). 
(G and H) Cells were transfected with either AGT  AB alone (G) or normal AGT alone (H), cultured in the presence of CCCP, and single 
labeled for AGT. Bar, 10 Ixm. 
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COS cells, cultured either in the presence or absence of 
CCCP, indicate that the rate of dimerization is similar in 
either the cytosol or the mitochondria. These observations 
suggest  that  the  differences in  AGT  AB  dimerization  in 
vitro and in vivo reflect differences in time scale rather 
than organelle-dependent variations in the rate of AGT  AB 
dimerization. 
Discussion 
The results  of the present study, together with previous 
studies (26, 27), demonstrate that the peroxisome-to-mito- 
chondrion mistargeting of AGT in PH1 is the combined 
effect of (a) the generation of an NH2-terminal mitochon- 
drial targeting sequence solely caused by the presence of 
the A  substitution; and (b) the inhibition of dimerization 
caused  by the  presence of both  A  and  B  substitutions. 
These observations are consistent with previous studies of 
the  structural  requirements  for  mitochondrial  import, 
which suggest that oligomerization of proteins inhibits im- 
port into the mitochondria. For example, disruption of a 
domain  required  for trimerization of a  CAT  passenger 
protein has been shown to be required for the in vivo im- 
port into mitochondria of an apo-iso-l-cytochrome c/CAT 
fusion (23). Similarly, deletion of an internal segment of 
the 13 subunit of mitochondrial F1-ATPase needed for tet- 
ramerization has been shown to eliminate the requirement 
for ATP in in vitro mitochondrial import (4). In a previous 
study, however, we reported that the A  substitution alone 
was sufficient to direct the import of in vitro-translated 
AGT into isolated mitochondria (26). How can that data 
be reconciled with the results of the present study, which 
indicate that both A and B substitutions are required to in- 
hibit AGT dimerization and thereby allow mitochondrial 
import? Reexamination of our previous data indicates that 
the presence of the A  substitution alone enables only a 
small proportion of AGT to be imported into the mito- 
chondria (possibly <10%; 26). It is possible that because 
of relatively slow protein folding and oligomerization in 
reticulocyte lysates, a small proportion of AGT molecules 
remain  undimerized.  Importantly,  in  transfected  cells, 
where protein folding and  oligomerization might be ex- 
pected to be more efficient, the A substitution alone is un- 
able to direct the mitochondrial import of detectable lev- 
els of AGT (21). Additionally, studies of the intracellular 
distribution of AGT in an individual homozygous for the 
A  substitution alone indicate that the majority of the pro- 
tein  (>90%)  is  correctly  localized  in  peroxisomes,  al- 
though some mistargeting to the mitochondria was clearly 
detectable (27). Therefore, in whole cells it appears that 
rapid dimerization excludes all but a few percent of AGT  A 
molecules from the mitochondrial import pathway, despite 
the presence of an MTS. 
The observation that the dimerization of AGTAB-myc 
with AGTA1 can completely block the mitochondrial im- 
port of AGTAB-myc suggests that AGT dimerization pre- 
cedes mitochondrial import in cells, and that once formed, 
the AGT subunits do not subsequently become available 
for mitochondrial import. If, as our data indicates, AGT 
dimerizes rapidly in the cytosol, the question arises as to 
whether AGT dimers are substrates for peroxisomal im- 
port or whether peroxisomal import precedes dimeriza- 
tion. Two pieces of data lead us to conclude that  AGT 
dimers are the substrates for peroxisomal import in whole 
cells.  First,  the  peroxisomal  localization  of  AGT-myc, 
when  coexpressed  with  normal  AGT,  establishes  that 
AGT dimers can at least be committed for peroxisomal 
import intact.  Second, when expressed alone, AGT  AB is 
predominantly localized to mitochondria, suggesting that 
mitochondrial import precedes peroxisomal import. How- 
ever, mitochondrial import of AGT  AB can be blocked by 
dimerization with normal AGT. Therefore, dimerization 
precedes mitochondrial import. One caveat to this argu- 
ment might be that the combined presence of the A and B 
substitutions in some way interferes with peroxisomal im- 
port. However, this does not seem to be the case because 
when AGT  Aa was expressed in cells treated with CCCP, 
the  protein  localized exclusively to peroxisomes.  Previ- 
ously, we have shown that neither the A  nor B mutation 
alone interferes with peroxisomal import (21). Although 
the MTS generated by the A substitution is unusual in that 
it is not cleaved (26), it is likely that mitochondrial import 
precedes peroxisomal import, even when a normal MTS is 
present. For example, recent studies have shown that in fe- 
line AGT, which contains a classical cleavable mitochon- 
drial  targeting presequence, mitochondrial import  takes 
precedence over peroxisomal import (23a). In such a case, 
it  appears  that  the  presence  of the  MTS  itself inhibits 
AGT dimerization (our unpublished observations). 
Early studies of the kinetics of peroxisomal protein oli- 
gomerization and  import supported  a  model of protein 
translocation in which proteins were imported in a mono- 
meric state and subsequently oligomerized in the peroxi- 
somal matrix. Thus, de Duve and Lazarow (15, 16) showed 
that  in  whole-liver  pulse  chase  experiments,  catalase 
monomers associated with peroxisomes in vivo before be- 
ing converted to tetramers. Similarly, Goodman et al. (11) 
demonstrated that the kinetics of oligomerization and per- 
oxisomal  import  of  alcohol  oxidase,  an  octameric  fla- 
voprotein from Candida  boidinii,  were similar, a  finding 
that  was  interpreted  as  indicating  that  monomers  are 
translocated into peroxisomes, where they then octamerize. 
More recently, however, several new lines of evidence 
have required a reevaluation of this model. First, cell fu- 
sion of fibroblasts from complementary Zellweger lines in- 
dicated that a preexisting pool of cytosolic, tetrameric cata- 
lase could be translocated into newly generated peroxisomes 
that are produced upon fusion (2). Second, studies of the 
oligomerization of catalase in normal human  fibroblasts 
using conformation-specific antibodies have suggested that 
catalase assembles  into a  tetramer in the cytosol before 
becoming associated  with peroxisomes (20).  These data 
are apparently at variance with earlier reports that indi- 
cated that the import of catalase was inhibited by amino- 
triazole, a compound that covalently binds to and inhibits 
catalase (19). In this study, it was suggested that binding of 
aminotriazole might  inhibit  peroxisomal import by pre- 
venting the dissociation of catalase subunits. An alterna- 
tive interpretation of these data, however, might be that 
aminotriazole exerts its effect by binding to and in some 
way obscuring specific targeting sequences within catalase. 
The third and by far the most persuasive piece of evi- 
dence supporting  a  model of oligomeric protein import 
Leiper et al. Dimerization and AGT Intracellular Targeting  949 Figure 7.  Chemical cross-linking  of human liver AGT. (A-C) Postnuclear supernatants of human liver homogenates from a normal in- 
dividual in which AGT was entirely peroxisomal (PEROX1SOME), a PH1 patient in which AGT was >90% mitochondrial (MITO- 
CHONDRIA), and a panperoxisome disease  patient in whom AGT was entirely cytosolic (CYTOSOL) were cross-linked with increas- 
ing concentrations of the cross-linker BS3, as indicated. After cross-linking,  proteins were resolved by SDS-PAGE on either 10%  (A 
and B) or 12% (C) SDS-PAGE gels and transferred to nitrocellulose membranes. AGT was visualized  by immunoblotting with rabbit 
anti-human AGT polyclonal serum followed by ECL. The migration positions of monomeric AGT (open arrow) and the two major 
cross-linking  products (I and I/) are indicated. (D) Normal human AGT was purified essentially  as previously described (35). Aliquots 
of the purified protein were cross-linked with increasing concentrations of the cross-linker BS3, as indicated. After cross-linking,  pro- 
teins were resolved by SDS-PAGE on 12% gels and visualized  by silver staining.  The migration positions of monomeric AGT (open ar- 
row) and the two major cross-linking  products (I and I/) are indicated. The positions of the molecular mass markers (in kilodaltons) are 
shown on the left-hand side of each gel. At the present time, we have no explanation for the higher cross-linking  efficiency of cytosolic 
AGT (C) than peroxisomal (A) or mitochondrial (B) AGT. We consider that it is unlikely to be related to the genotype of this individ- 
ual, who is heterozygous for the A mutation (7), since this mutation had no effect on AGT dimerization in vitro (see Fig. 1). We also 
think that it is unlikely to be related to the accessibility  of the cross-linker to AGT in the homogenates, since the liver samples were fro- 
zen and thawed before homogenization. Irrespective of this, it is clear that AGT  AB (B) can dimerize in vivo. 
into  peroxisomes  comes  from studies  of both  PTS1  and 
PTS2 import pathways in the yeast S. cerevisiae. Thus, Mc- 
New  and  Goodman  (18)  demonstrated  that  the  trimeric 
bacterial protein CAT, fused to a  COOH-terminal PTS1- 
bearing  peptide,  is  imported  into  yeast  peroxisomes. 
When  the rates  of trimerization  and  peroxisomal  import 
were  determined,  trimerization  clearly preceded  import. 
In similar studies,  Glover et al.  (10) examined the dimer- 
ization and import of thiolase, a PTS2 containing protein. 
A  mutant form of thiolase from which the PTS2 had been 
deleted  was imported  into peroxisomes  only when coex- 
pressed with normal thiolase, suggesting that in yeast, oli- 
gomeric  protein  import  may  extend  to  both  PTS1  and 
PTS2 pathways. A  clear demonstration that macromolecu- 
lar  structures  (whether  monomers  or  oligomers)  can  be 
imported into peroxisomes has been provided by the work 
of Walton and colleagues (37). These authors have exam- 
ined the import competence of a number of artificial per- 
oxisomal substrates ranging from HSA to 9-nm gold parti- 
cles by microinjection  into fibroblasts.  When  conjugated 
to numerous  12-amino acid peptides  that  terminate  with 
the PTS1 tripeptide SKL, HSA was imported into peroxi- 
somes.  Chemical cross-linking  of the  albumin  moiety, to 
prevent  unfolding before  import,  did  not inhibit  import, 
suggesting  that  highly  folded  molecules  can  be  translo- 
cated across the peroxisomal  membrane.  This  suggestion 
was strengthened  by the finding that  9-nm gold particles 
coated  with  the  HSA-peptide  conjugates  were  also  im- 
ported into peroxisomes. 
The unparalleled  peroxisome-to-mitochondrion mistar- 
geting of AGT in PH1 has provided a unique opportunity 
to compare  and  contrast  the  structural  requirements  for 
protein import into these two organelles. The results pre- 
sented in this paper provide the first evidence for the oli- 
gomeric peroxisomal import of a naturally occurring PTS1 
protein,  and  they  demonstrate  a  novel  mechanism  by 
which enzyme mistargeting can lead to a lethal human he- 
reditary disease. 
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